FDA to host webinar on drug supply chain safety

June 25, 2014

On July 1, 2014, FDA’s Center for Drug Evaluation and Research Small Business and Industry Assistance (CDER SBIA) will host a webinar designed to help manufacturers, repackagers, wholesale distributors, and dispensers identify suspect products.

On July 1, 2014, FDA’s Center for Drug Evaluation and Research Small Business and Industry Assistance (CDER SBIA) will host a webinar designed to help manufacturers, repackagers, wholesale distributors, and dispensers identify suspect products.

The webinar is entitled: “An Overview of FDA’s Draft Guidance - Drug Supply Chain Security Act Implementation: Identification of Suspect Product and Notification.”  It will begin at 1 pm EST.

“These focused webinars support the CDER SBIA’s mission of promoting productive interaction with regulated industry by assisting small pharmaceutical business and industry with information relating to the development and regulation of human drug products,” FDA wrote. “The purpose of this webinar is to provide an introduction and overview of FDA’s recently issued draft guidance….This is the first guidance issued under the Drug Supply Chain Security Act.”

The webinar’s featured speaker will be Carolyn Becker, a senior regulatory counsel in the FDA’s office of compliance.

Click here to register for the webinar.